Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: BIPMF - Biophage Pharma, Inc.

30 Apr 2007 07:32 PM <--

29 Jul 2006 09:04 AM

28 Jul 2006 01:25 AM

25 Jul 2006 01:37 AM

Return to BIPMF - Biophage Pharma, Inc.

Biophage Pharma, Inc. (Pink BIPMF) (aka: TVX - BUG): is a Canadian biopharmaceutical company developing new therapeutic and diagnostic products using phage-based nano-technology. Founded in 1995, Biophage is located at the Biotechnology Research Institute in Montreal. Through an active R&D program, as well as in-licensing and collaboration agreements, Biophage is building a portfolio of promising new products in two different programs: (A) The Diagnostic program & (B) The Therapeutic program Website: biophagepharma.com